genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
Atopic dermatitis
Industry News
Celsus Acquires Volution Immuno Pharmaceuticals, Creating Orphan Drug Developer
News
Stiefel Pays Welichem C$35M for Topical Agent for Psoriasis, Atopic Dermatitis
Drug Discovery
U.S. Govt Adds $32M to $512M Smallpox Vaccine Contract with Bavarian Nordic
News
Meda Outlicenses Elidel and Xerese to Valeant for $76M Up Front
Infectious Diseases
Anacor and MMV Team Up to Take Malaria Candidate Through to Proof-of-Concept
Drug Discovery
Circassia Takes on Airmid’s Psoriasis and Atopic Dermatitis Candidate
News
Transcription Factor Therapeutics Obtains Rights to Anesiva’s NF-kappa B Program
1
2
3
Page 3 of 3
Scroll Up